###### Key Messages

This multi-ethnic cohort has provided comparative prevalence rates among the major ethnic groups in Malaysia.The prevalence data confirmed the increasing trends of type 2 diabetes, hypertension and hypercholesterolaemia in Malaysia.The comparison of the urban and rural populations showed similarity in terms of prevalence of lifestyle diseases due to modernization

Why was the cohort set up?
==========================

Malaysia's population of 28.3 million, based on the 2010 national census, is multi-ethnic with the three major ethnic groups making up 95% of the total population.[@dyu089-B1] Malays contribute to 63.1% of the population, Chinese 24.6% and Indians 7.3% and the rest is made up of other smaller ethnic groups in East and West Malaysia plus a small population of aborigines.

Non-communicable diseases are fast emerging and becoming the major cause of morbidity and deaths in Malaysia, similar to that in the USA or other developed nations. It is clear that with the increasing modernization and standard of living in Malaysia since its independence in 1957, there has been a major change in lifestyle which includes diet as well as physical activity. The data from the National Health Morbidity Survey II (NHMS II) in 1996 conducted by the Ministry of Health Malaysia showed an 8.3% prevalence of diabetes among the adult population aged ≥18 years.[@dyu089-B2] The NHMS III in 2006 showed that the prevalence of diabetes has increased to 11.6% and this increased further in the NHMS IV to 15.2%.[@dyu089-B3]^,^[@dyu089-B4] This is rather alarming and there is a similar pattern of increasing diabetes prevalence elsewhere in Asia.[@dyu089-B5] For hypertension, the prevalence in the NHMS II was 33% and this increased to 42.6% in the NHMS III. The trend is again similar to some of our Asian neighbours like Thailand and Singapore.[@dyu089-B6]

As part of the government's increasing efforts to address and investigate the rising trends of non-communicable diseases, the cabinet approved The Malaysian Cohort study in 2005. The top-down approach ensured funding was given to sustain the project at least for the first 5 years. The study proposal was prepared by a team of local experts from various disciplines. Malaysia is a member of The Asia Cohort Consortium whose membership includes South Korea, Japan, China, Taiwan, Singapore, India and the USA.

The Malaysian Cohort aimed to recruit a total of 100 000 individuals from the various ethnic groups. This number is smaller in proportion to the population when compared with the UK Biobank study which has recruited 500 000 participants from a population of 50 million. Nevertheless, we believe it has become a valuable cohort to have, that is now a national resource for researchers in Malaysia as well as providing us with an opportunity to collaborate with international institutions. We have completed the recruitment of the targeted number of participants and we would like to report and share our experience and baseline data with others. As one of the newest cohorts amongst developing nations, we also would like to share the unique experience and the challenges in developing such a study in a tropical and multi-ethnic country like Malaysia.

The primary objectives of TMC project are: (i) to study and determine the roles and interaction of genes, environment and lifestyle in various diseases through a large-scale population cohort study; (ii) to discover biomarkers for cancers and other diseases using the genomics and proteomics approach which would eventually lead to early detection and prevention of diseases; (iii) to consolidate and sustain the initiative for research in life sciences through a systematic discovery programme and also international collaborative research; and (iv) to establish a rich database of information and a bank of biospecimens which will become a national resource for research.

Who is in the cohort?
=====================

The Malaysian Cohort study was designed to recruit a total of 100 000 participants aged 35--70 years. The study was approved by the institutional review and ethics board of the Universiti Kebangsaan Malaysia. The study approach included using an interview-based questionnaire and various biophysical measurements plus the collection, processing and storage of biospecimens.

Sampling
--------

The cohort sampling was performed using a mixed approach of voluntary participation (through advertisements and publicity campaigns) as well as cluster and targeted sampling. The cluster sampling was used for the rural areas. The rural areas were chosen from the government's Federal Land Development Authority (FELDA) agricultural scheme which was set up in 1956 and focused on the farming of rubber and oil palm. There are currently about 112 000 settlers working in 103 of these settlements throughout Malaysia, and a total of 75 settlements were sampled. A total of 25 907 invitations were sent out to those who fulfilled the age criteria and 19 467 people (75.1%) responded and were recruited. The FELDA cohort is a relatively non-mobile population and provided an advantage for future follow-up and visits. For the urban areas, the participants were recruited from publicity events which were held in cities, towns, government offices, private agencies and housing areas as well as newspaper advertisements. Between April 2006 and September 2012, a total of 106 527 participants were enrolled into the study. The demographic characteristics of the participants and the comparison with the Malaysian population (as of Census 2010) are shown in [Table 1](#dyu089-T1){ref-type="table"}. Table 1.Demographic characteristics of the 106 527 participants in The Malaysian Cohort (2006--12) compared with the general Malaysian population (Census 2010[^a^](#dyu089-TF1){ref-type="table-fn"})DemographicTMC (2006--12)Malaysian population (Census 2010[^a^](#dyu089-TF1){ref-type="table-fn"})Place of residencePlace of residenceNumber of participantsUrban (%)Rural (%)Number of peopleUrban (%)Rural (%)Gender    Male44 89771.828.214 562 63870.729.3    Female61 63071.128.913 771 49771.428.6Ethnicity    Malay46 78252.447.614 191 72066.633.4    Chinese34 62496.83.26 392 63691.09.0    Indian16 21886.813.21 907 82789.110.9    Other890345.055.05 841 95254.046.0Age range (years)    35--4430 29380.020.03 690 09374.026.0    45--5445 90970.629.42 974 60271.628.4    55--6429 07464.135.91 888 61868.631.4    65--70125165.334.71 427 34064.435.6[^1]

The inclusion criteria included being a Malaysian citizen and in possession of a valid identification card, not suffering from any acute illness at the time of study and giving informed consent to the study. Those excluded include those with debilitating illnesses including cancers and those who refused consent. A four-layered written informed consent was taken which covers consent for: (i) the study interview; (ii) the biophysical examination; (iii) blood taking, baseline blood tests and storage of biospecimens; and (iv) future research.

Recruitment centres
-------------------

The main recruitment centre was based at The Malaysian Cohort office at the Universiti Kebangsaan Malaysia Medical Centre (UKMMC) in Kuala Lumpur. We also had two mobile teams recruiting in the other cities, towns, housing areas and the rural areas. Each of the three recruitment teams consisted of 20--24 personnel including enumerators, phlebotomists, laboratory technicians and data assistants. The mobile teams were also equipped with a mobile laboratory to ensure the preservation of biospecimens in rural areas where electricity supply was a problem, and transportation vans to transport the biospecimens within 24 h from the recruitment sites to the central processing site at the UKMMC. For recruitment in East Malaysia, biospecimens were transported via air shipment.

How are the participants being followed up?
===========================================

Follow-up and endpoints
-----------------------

Each participant was given a health diary to fill up and return to the TMC office every 6 months. This was to record all illnesses, visits to health facilities, medications and procedures, cost of each treatment and source of payment. Due to the low percentage of the return of these self-report forms, we decided to set up a team to call each participant every 6 months and interviewed them based on the health diary. All participants have either a home phone or a mobile phone. This approach has been successful in getting the follow-up data by phone in 70% of the participants. We have not managed to contact by phone a total of 31 957 (30%) participants, and the reasons for this include not answering the phone (43.2%), voice mail response (21.6%), no ringing tone (15.5%), number not in service (11.8%), wrong number (5.4%) and missing contact number (2.5%). Migration or change of address could also be a cause. The differences between the group which was successfully followed up and the group which we failed to contact are shown in [Table 2](#dyu089-T2){ref-type="table"}. A comprehensive follow-up is targeted every 5 years, where each participant will again interviewed, biophysical measurements repeated and biospecimens collected. The invitations to the 5-yearly revisits are issued by phone and through invitation letters posted to their addresses. For the 30% non-responders, our mobile teams will trace them via home visits. Table 2.Socio-demographic and health differences between those successfully and unsuccessfully followed up by telephone among 106 527 participants of The Malaysian Cohort[^a^](#dyu089-TF2){ref-type="table-fn"}Demographic and health differencesSuccessful (*N*=74 653)Unsuccessful (*N*=31 874)*P*-valueNumber of participantsUrban (%)Rural (%)Number of participantsUrban (%)Rural (%)Gender    Male32 25574.925.112 64264.036.0χ^2^ = 115.1    Female42 39874.425.619 23263.836.2*P \< 0.001*Ethnicity    Malay31 60355.444.615 17946.253.8    Chinese25 76496.93.1886096.23.8χ^2^ = 1093.9    Indian12 02687.912.1419283.516.5*P \< 0.001*    Other526051.049.0364336.463.6Risk factors    Hypertension34 46470.729.314 95458.841.2    Diabetes mellitus12 07268.431.6552357.942.1χ^2^ = 221.5    High cholesterol33 10672.627.414 01462.337.7*P \< 0.001*    Obesity12 94667.932.1582057.542.5[^2]

In Malaysia, every citizen is provided with a national identification card (IC) which has a unique number for each individual. For the mortality data, the IC numbers of the participants were sent every 6 months to the National Registration Department (NRD). The NRD provided us with the mortality data and the cause of death.

What has been measured?
=======================

Questionnaire and interview
---------------------------

The questionnaire was developed by The Malaysian Cohort Study Group with the assistance of advisers from the Asia Cohort Consortium. Several questionnaires from the Korean Cohort study, the Singapore Chinese Health Study and the Fred Hutchinson Cancer Research Centre, USA, were used with permission as references. The questionnaire covered information on demography, occupational history, use of tobacco and alcohol, diet and physical activity, menstrual and reproductive history (women) and medical history. The diet component consisted of a 24-h recall and a 2-day food record. The physical activity questionnaire was adapted from the short version of the international physical activity questionnaire (IPAQ). The questionnaire was uploaded onto tablet personal computers with touch-screen features. Key pop-up features included a data dictionary as well as a digital diet album, to assist both the enumerators and the participants. Each participant was interviewed face to face at the central recruitment centre or at the mobile sites by a trained interviewer.

Quality control of interviews
-----------------------------

We introduced a quality control system for the data obtained from the interviews. Each interview was recorded, with consent, using the tablet computer recording system as well as an MP3 player. Every interview recording was listened to and audited by an independent enumerator. The errors were coded and rectified accordingly.

Biophysical measurements
------------------------

Each participant had the following measurements taken: height using the Harpenden stadiometer, weight (Seca weighing scale), BMI, waist and hip circumference, waist-to-hip ratio, body composition analysis using the InBody 720 system (Biospace), lung function test using a spirometer (model SP260 by Schiller), blood pressure (HEM-907 model by OMRON) and electrocardiogram. Each measurement was taken three times where possible and underwent quality control processes before the data were uploaded into the database.

Biospecimens
------------

We used the UK Biobank protocol as our reference standards for the collection of blood and urine.[@dyu089-B9] All participants came fasted. A total of 40 ml blood and 20 ml urine were donated by each participant. After processing, each participant had 54 cryovials of biospecimens. Half of the cryovials were kept in −80°C freezers and the other half in liquid nitrogen tanks. We used 1-ml Nunc Cryotubes with a 2-D barcoding system (Thermo Scientific, USA) to allow for a systematic inventory system as well as for easy sample tracking and retrieval. The freezers and liquid nitrogen tanks were housed in The Malaysian Cohort Biobank which has an online temperature monitoring system.

Baseline measurements
---------------------

We measured fasting blood glucose, fasting cholesterol (later full lipid profile after the 50 000th participant), full blood count and renal profile (after the 50 000th participant). Calibration of equipments (Roche Integra and Beckman Coulter) was performed regularly and correlation studies were performed with the hospital's chemical pathology diagnostic laboratory to ensure validity of the results.

Feedback of baseline results to the participants
------------------------------------------------

The results from the biophysical measurements, fasting blood sugar, fasting cholesterol and full blood count were compiled into a one-page summary report and posted to each participant within 2 weeks of recruitment. The report also contained basic explanation on what the normal values were. Those with abnormal results were advised to see their doctor for further investigation and treatment.

Follow-up beginning in June 2013
--------------------------------

For the follow-up, we are using the same questionnaire with some minor modifications. Biophysical measurements remain the same but we have added the measurement of cardio-ankle vascular index (CAVI). We are collecting a total of 30 ml blood and 20 ml urine at follow-up. For the blood tests, we added measurement of T4 and thyroxine stimulating hormone (TSH) levels as well as HbA1c levels for those with diabetes.

What has The Malaysian Cohort study found?
==========================================

Baseline demographic characteristics and habits
-----------------------------------------------

As of 30 September 2012, we have recruited a total of 106 527 participants from all over Malaysia. [Figure 1](#dyu089-F1){ref-type="fig"} shows the distribution of all 151 recruitment locations. The breakdown of the participants in terms of age, sex, ethnicity, location (urban or rural), educational level, smoking and alcohol intake is shown in [Table 3](#dyu089-T3){ref-type="table"}. There were more women than men. We oversampled the Indians and Chinese to allow us to have more events in these two ethnic groups for comparison with the Malay ethnic group in future research. The prevalences of smoking and alcohol intake among TMC are 26.6% and 5.4%, respectively ([Table 3](#dyu089-T3){ref-type="table"}). Figure 1.The Malaysian Cohort's 151 recruitment locations, comprising 95 rural (filled circles) and 56 urban (unfilled circles) locations. Table 3.Demographic characteristics, educational level, smoking habit, alcohol use and prevalences of diseases according to ethnicity and age group among the 106 527 participants in The Malaysian Cohort (2006--12)[^a^](#dyu089-TF3){ref-type="table-fn"}Baseline characteristics (*N* = 106 527)Men, by age (years)[^a^](#dyu089-TF3){ref-type="table-fn"} *N* = 44 897Women, by age (years)[^a^](#dyu089-TF3){ref-type="table-fn"} *N* = 61 630Total (%)Chi-square35--4445--5455--6465--7035--4445--5455--6465--70χ2*P*-valuePlace of residence    Urban81.873.862.059.878.968.466.173.471.46.8\<0.001    Rural18.226.238.040.221.131.633.926.628.6Ethnicity    Malay40.244.950.047.638.246.342.733.743.9292.4\<0.001    Chinese31.429.228.636.334.532.637.654.432.5    Indian17.817.014.610.116.513.613.57.715.2    Others10.68.96.86.010.87.56.24.28.4Highest educational level    University/college39.527.020.610.331.020.116.94.524.81173.9\<0.001    Secondary school50.951.237.027.856.446.928.821.445.6    Primary school9.220.840.359.011.529.345.453.526.6    No schooling0.41.02.12.91.13.78.920.63.0Tobacco smoking    Yes59.658.456.655.15.23.22.94.526.639 178.0\<0.001Alcohol drinking    Yes11.811.49.89.51.81.21.00.85.44731.5\<0.001Prevalence    Hypertension32.346.762.170.925.547.465.080.146.5100.4\<0.001        Malay30.745.360.572.029.652.169.283.649.2608.8\<0.001        Chinese31.344.662.768.918.638.858.877.241.7        Indian34.150.163.263.523.445.965.384.645.7        Others38.754.269.986.435.958.773.881.052.9    Diabetes mellitus9.918.326.727.37.315.323.327.316.6310.3\<0.001        Malay9.818.627.029.28.419.129.232.719.23376.7\<0.001        Chinese5.710.918.622.73.36.712.222.29.1        Indian19.933.445.641.913.925.238.048.728.3        Others5.812.517.516.35.811.818.89.511.1    High cholesterol38.747.851.356.525.245.861.664.444.9112.1\<0.001        Malay44.954.056.660.930.451.566.466.751.01381.0\<0.001        Chinese34.042.346.354.721.741.459.163.440.8        Indian37.847.649.552.722.240.758.668.441.6        Others31.435.037.939.022.238.850.352.434.4    Obesity16.414.612.17.019.821.319.010.817.7650.2\<0.001        Malay18.817.715.110.925.729.126.817.522.93554.8\<0.001        Chinese11.47.86.71.97.87.37.45.17.8        Indian20.218.314.09.329.627.926.923.123.4        Others15.714.59.64.422.622.018.19.518.0Number of participants11 45118 46214 24074418 84227 44714 834507106 527[^3]

Validation studies
------------------

Three validation studies are being performed including urine cotinine levels for smoking history, serum carotenoids for fruit and vegetable intake plus a validation study for physical activity using the Actical accelerometer.

Baseline prevalence data and mean values of measurements
--------------------------------------------------------

The baseline prevalence data of diabetes, hypertension, hypercholesterolaemia and obesity from the 106 527 participants are also shown in [Table 3](#dyu089-T3){ref-type="table"}. We used the level of ≥7.0 mmol/l as the cut-off point for diabetes \[World Health Organization (WHO) criteria\] and the 6.21 mmol/l for hypercholesterolaemia (National Institutes of Health, USA).The prevalence of type 2 diabetes of 16.6% is comparable to the 14.6% prevalence obtained from the National Health Morbidity Survey in 2011, although our cohort involved an older starting age group. There are differences in the prevalence of diabetes and obesity between the Chinese (lower prevalence) vs the Malays and Indians. This has provided key opportunities for genome-wide association studies (GWAS) as well as gene-environment-lifestyle comparison between ethnic groups. A genome-wide association study on type 2 diabetes is currently being done. [Table 4](#dyu089-T4){ref-type="table"} shows the presence of risk factors either singly or in combination. A total of 43.4% of the participants have more than one risk factor. The mean values of baseline measurements and blood tests are shown in [Table 5](#dyu089-T5){ref-type="table"}. There are differences between the values among men and women and also between the age groups. Table 4.Presence of risk factors among the 106 527 participants in the TMCRisk factors (hypertension, diabetes, hypercholesterolaemia and obesity)Number of participants% of totalNo risk factor26 58825.0One risk factor    Hypertension only11 08310.4    Diabetes only17001.6    Hypercholesterolaemia only13 73812.9    Obesity only71436.7Sub-total33 66431.6Two risk factors    Hypertension + diabetes21122.0    Hypertension + hypercholesterolaemia10 70810.1    Hypertension + obesity75197.1    Diabetes + hypercholesterolaemia18751.8    Diabetes + obesity11061.0    Hypercholesterolaemia + obesity45154.2Sub-total27 83526.1Three risk factors    Hypertension + diabetes + hypercholesterolaemia36323.4    Diabetes + hypercholesterolaemia + obesity9940.9    Hypercholesterolaemia + obesity + hypertension77767.3    Obesity + Hypertension + Diabetes only23042.2Sub-total14 70613.8Four risk factors    Hypertension + diabetes + hypercholesterolaemia + obesity37343.5Total106 527100.0 Table 5.Mean values of baseline measurements and blood tests according to age group and gender among 106 527 participants in The Malaysian Cohort[^a^](#dyu089-TF4){ref-type="table-fn"}MeanMen (*N* = 44 897) by age groupWomen (*N* = 61 630) by age group*P*-value35--4445--4455--6465--7035--4445--4455--6465--70Systolic blood pressure (mmHg)124.8 ± 14.5128.6 ± 16.9133.2 ± 19.3137.1 ± 21.3117.1 ± 15.9126.5 ± 19.2133.0 ± 20.5140.4 ± 22.3\< 0.001Diastolic blood pressure (mmHg)82.9 ± 10.984.0 ± 11.483.1 ± 11.681.0 ± 12.079.7 ± 11.683.0 ± 12.282.4 ± 11.681.1 ± 11.7\< 0.001Fasting blood glucose (mmol/l)5.8 ± 1.76.2 ± 2.26.5 ± 2.46.3 ± 2.05.5 ± 1.56.0 ± 2.16.3 ± 2.46.3 ± 2.1\<0.001Total cholesterol (mmol/l)5.7 ± 1.15.8 ± 1.25.9 ± 1.25.9 ± 1.25.5 ± 0.95.9 ± 1.26.1 ± 1.26.2 ± 1.2\< 0.001HDL cholesterol (mmol/l)1.2 ± 0.31.2 ± 0.31.3 ± 0.31.3 ± 0.41.5 ± 0.41.5 ± 0.41.5 ± 0.41.6 ± 0.5\< 0.001LDL cholesterol (mmol/l)3.7 ± 1.03.7 ± 1.03.5 ± 1.13.6 ± 1.23.3 ± 0.93.6 ± 1.03.7 ± 1.13.7 ± 1.1\<0.001Triglycerides (mmol/l)1.8 ± 1.31.8 ± 1.21.7 ± 1.11.6 ± 0.91.2 ± 0.81.4 ± 0.81.5 ± 0.91.6 ± 0.7\<0.001BMI (kg/m^2^)26.2 ± 4.426.0 ± 4.125.6 ± 4.024.7 ± 3.626.0 ± 5.226.5 ± 4.926.2 ± 4.825.0 ± 4.1\<0.001[^4]

Mortality data from 2007--13
----------------------------

[Table 6](#dyu089-T6){ref-type="table"} shows the mortality data and the causes of death since we started recruitment in 2006, up to June 2013. The cause of deaths according to the cancer types are also shown within [Table 6](#dyu089-T6){ref-type="table"}.[@dyu089-B10] The calculated crude mortality rate for the cohort is 1284 per 100 000 person-years. Table 6.Causes of death and number of cases (based on ICD-10) contributing to the mortality in The Malaysian Cohort from commencement of recruitment until June 2013Main cause of deathNumber of cases (%)Diseases of the circulatory system440 (32.2)Neoplasms    Lung (49 cases)    Liver (35 cases)    Breast (35 cases)    Colorectal (16 cases)    Stomach (14 cases)    Nasopharyngeal (13 cases)    Lymphoma (13 cases)    Brain (13 cases)    Ovarian (11 cases)    Pancreatic (11)    Unknown (11)    Other (45)266 (19.4)Certain infectious and parasitic diseases189 (13.8)Ageing128 (9.3)Diseases of the respiratory system116 (8.5)Injury, poisoning and similar55 (4.0)Endocrine, nutritional and metabolic diseases48 (3.5)Unknown/other31 (2.3)Diseases of digestive system29 (2.1)External causes of morbidity and mortality24 (1.8)Diseases of the genitourinary system20 (1.5)Symptoms, signs & abnormal clinical and laboratory findings, not elsewhere classified16 (1.2)Diseases of the nervous system4 (0.3)Diseases of the skin and subcutaneous tissue2 (0.1)Total1368 (100)

What are the main weaknesses and strengths?
===========================================

Strengths
---------

A top-down project approved at the cabinet level ensured the sustained funding from 2005--13.The establishment of the first large population-based cohort study in Malaysia has comprehensive assessments of exposure, diet and physical activity, biological specimens (blood and urine) and 6-monthly follow-up data.Many innovative technologies were used, including e-questionnaire (the questionnaire was downloaded to tablet PCs and used by the enumerators to interview the participants), mapping of each participant's address using the Geographical Information System (GIS) and a mobile laboratory for use in the rural communities. The questionnaires were also translated into English, Mandarin and Tamil.The use of GIS has given us the opportunity to map and layer the environmental data and to facilitate the study of many aspects of diseases including gene-environment interaction.The development of our own in-house Cohort Information Management System (CIMS) manages many key aspects of the study including registration, questionnaire data, biophysical data, results of blood tests, biobank and follow-up data.Extensive quality control of data includes listening to audio recording of interviews to detect and correct errors, and checking of biophysical data.The Cohort biobank follows strictly international standards of biobanking and we also use the UK Biobank procedures as a main reference. Our bioanalytical laboratory for testing blood sugar, lipid profile, renal profile and full blood count was given the ISO15189 certification from the Department of Standards Malaysia in November 2011.

Weaknesses
----------

The The urban Cohort population was somewhat non-representative as we allowed anyone who fulfilled the criteria and those who signed up during our publicity campaigns to contact our call centre and make an appointment to become a participant. However, for the rural community in the agricultural settlements we might have a more representative sample for the population as cluster sampling was used. The data in [Table 1](#dyu089-T1){ref-type="table"} have clearly shown the similarities and differences between the TMC participants and the general Malaysian population. There will certainly be limitations in terms of representativeness and we shall be cautious when using the TMC data in future studies especially in those looking at non-genetic associations.The failure to contact about 30% of the participants during the 6-monthly phone call was due to migration, transfer of place of work or change in telephone numbers. Measures are being taken to trace them via letters or electronic mail as well as home visits.Systematic update of exposure data is only now possible as we have completed the target recruitment of 100 000 participants 5 years after the first baseline recruitment. The health diary interview conducted every 6 months covered mainly changes in health status plus treatment.We had difficulty in obtaining clinical samples at the time of admission for diagnosis of diseases such as cancers. Having tissue samples would certainly add value to future studies.

Can I get hold of the data? Where can I find out more?
======================================================

Information on The Malaysian Cohort is available at ([www.mycohort.gov.com](http://www.mycohort.gov.com)). Requests for other data or information can be made to the author via e-mail. We welcome national and international collaborations and proposals can be forwarded to (<rahmanj@ppukm.ukm.edu.my>) and they will then be discussed at the steering committee.

Funding
=======

The project is funded by a top-down grant from the National Biotechnology Division, Ministry of Science, Technology and Innovation (MOSTI), Malaysia (ER-05-01-02-MEB001). The grant is administered by the Malaysia Genome Institute, MOSTI. Additional funding, including infrastructure and utilities, is provided by the Universiti Kebangsaan Malaysia.

We thank all the members of The Malaysian Cohort Study Group, all TMC staff members and research assistants. The voluntary participation of all the participants is greatly appreciated. We also thank all the community leaders and the officers from the local authorities involved who have assisted us in the recruitment processes. We are also grateful to the management of the Universiti Kebangsaan Malaysia Medical Centre for providing the space for the TMC office, recruitment centre and the biobank.

The Malaysian Cohort Study Group includes:

Abd Rashid Abd Rahman, Afifah Awang, Ahmad Taufik Jamil, Amal Nasir Mustafa, Amin Ariff Nuruddin, Amin Ismail, Aminuddin Abd Hamid Karim, Amrizal Muhd Nur, Andri Dauni, Atiya Ab Sallam, Christopher Lee, Deepak Rebentisch, Lim Chin Chye, Fauzi Md Anshar, Ghufran Ridzuan, Hashami Bohari, Hayati Aziz, Hejar Abdul Rahman, Ikram Shah Ismail, Ismail Noor, Jamaiyah Haniff, Jamal Hisham Hashim, Jamalludin Ab Rahman, Khadijah Shamsuddin, Krishna Gopal Rampal, Lokman Hakim Sulaiman, Mirnalini Kandiah, Mohamad Ariff Mohd Hashim, Mohd Hashim Omar, Mohd Nizam Isa, Mohd Rizal Abdul Manaf, Muhammad Amir Kamaluddin, Muhamad Nazeri Osman, Nik Mazlan Mamat, Noor Aini Mohd Yusof, Nor Azmi Kamaruddin, Nor Laili Mahat, Norimah Ab. Karim, Osman Ali, Ng Sien Kiat, Poh Bee Koon, Nurmaya Mustafa, Nurul Ain Md Yusuf, Rohaizat Yon, Roslan Harun, Rushidi Ramly, Rusli Ismail, Safiah Mohd Yusof, Salina Abd. Aziz, Salmaan Hussain Inayat Hussain, Salywana A Kamat, Samsuddin Osman Cassim, Saniah Than, Saperi Sulong, Sazaly Abu Bakar, Seri Suniza Sufian, Shahrul Azman Mohd Noah, Sirajuddin Hashim, Suzana Shahar, Syarifah Zainiyah Syed Yahya, Syed Mohd AlJunid, Tan Yoke Hwa, Tengku Mohd Tengku Sembok, Wan Abdul Manan Wan Muda, Wan Ahmad Faisal Wan Salam, Wan Mohamad Wan Bebakar, Wan Nazaimoon Wan Mohamud, Wan Zurinah Wan Ngah, Yasmin Anum Mohd Yusof, Zafar Ahmed, Zainal Ariffin Omar, Zarihah Zain, Zilfalil Alwi, Zulhabri Othman and Zulkifli Ahmad.

**Conflict of interest:** None declared.

[^1]: ^a^see *Population Distribution and Basic Demographic Characteristics 2010* (Department of Statistics Malaysia, 2010[@dyu089-B1]).

[^2]: ^a^All data are row percentages.

[^3]: ^a^All data are column percentages.

[^4]: ^a^Data are means ± SD.
